{"transactions":[{"id":734386,"issuer":{"id":7767,"kind":"organization","name":"NeuroSense Therapeutics Ltd."},"owners":[{"id":37316,"kind":"person","name":"Ben-Noon Alon","position":1,"cik":"0001901198","reported_name":"Ben-Noon Alon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-17T20:30:02.000Z","date":"2026-06-16","kind":"purchase","planned":false,"acquired":true,"shares":250000,"price":0.8,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended."}],"balance_after":4534233,"source":{"system":"sec-edgar","filing":"0001213900-26-069663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875091/000121390026069663/ownership.xml","form_type":"4"}}]}